We offer PBMC from subjects who verifiably have or have not been infected by SARS-CoV-2.
Product 1 – Subjects collected in the Pre-COVID era (11/2019) that are immunologically uncharacterized (negative controls)
Cat# CTL-PCOV-UP1 ≥10 million cells per vial $ 384/vial
Product 2 – Subjects with prior (PCR-verified) infection with SARS-CoV-2, collected after convalescence and characterized for T and/or B cell reactivity against SARS-CoV-2 antigens (positive controls)
Cat# CTL-PCOV-CP2 ≥10 million cells per vial $ 560/vial
Product 3 – Subjects collected in the Post-COVID era that exhibit memory B cell reactivity against SARS-CoV-2 Nucleocapsid or Spike antigens, suggesting past SARS-CoV-2 infection. (see reference)
Cat# CTL-PCOV-CP3 ≥10 million cells per vial $ 360/vial
For custom concentrations and volume discounts, please inquire at pbmc@immunospot.com
These cryopreserved PBMC are ideal for any applications that requires samples from subjects who verifiably have or have not been infected by SARS-CoV-2.
Pooled PBMC from an even number of healthy male and female donors. All donors are prescreened and selected per the European Pharmacopoeia guidelines: no NSAIDs administered for one week and no steroids for one month prior to aphaeresis. Independent functionality tests were performed to measure responses to endotoxin, lipoteichoic acid and peptidoglycan by ELISA to ensure a high background to response ratio.
Independent functionality tests have been performed to measure IL-6 responses to endotoxin, lipoteichoic acid and peptidoglycan by ELISA to ensure a high signal to background ratio.
Independent functionality tests have been performed to measure IL-6 responses to endotoxin, lipoteichoic acid and peptidoglycan by ELISA to ensure a high signal to background ratio.
